2022
DOI: 10.23876/j.krcp.21.078
|View full text |Cite
|
Sign up to set email alerts
|

The combined clinical impact of red blood cell distribution width and vascular calcification on cardiovascular events and mortality in patients with endstage kidney disease

Abstract: Background: Little is known about how the interaction between red blood cell distribution width (RDW) and vascular calcification (VC) affects cardiovascular (CV) events and mortality in end-stage kidney disease (ESKD) patients. This study investigated the combined prognostic effect of RDW and VC in ESKD patients starting dialysis. Methods: A retrospective single-center study of 582 ESKD patients was conducted. VC was assessed by calculating the aortic calcification index (ACI) using computed tomography. Patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…The combination of RDW and N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) improves the prognostic accuracy of heart failure (Liang et al, 2022). Both high RDW and vascular calcification contribute to the increased risk of cardiovascular events and death in patients with end‐stage kidney disease (Kim et al, 2022). Moreover, RDW and systemic immune inflammation were reported to be independent markers for hypertensive patients in predicting long‐term cardiovascular events (Uzun et al, 2022).…”
Section: The Application Of Rdw In the Diagnosis Of Nonanemic Diseasesmentioning
confidence: 99%
“…The combination of RDW and N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) improves the prognostic accuracy of heart failure (Liang et al, 2022). Both high RDW and vascular calcification contribute to the increased risk of cardiovascular events and death in patients with end‐stage kidney disease (Kim et al, 2022). Moreover, RDW and systemic immune inflammation were reported to be independent markers for hypertensive patients in predicting long‐term cardiovascular events (Uzun et al, 2022).…”
Section: The Application Of Rdw In the Diagnosis Of Nonanemic Diseasesmentioning
confidence: 99%